Related Experiment Video
Updated: Jun 27, 2026
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Do microRNAs regulate myocardial fibrosis?
1Division of Cardiovascular Sciences, Center of Applied Medical Research, University Clinic, University of Navarra, Pamplona, Spain. jadimar@unav.es
Abstract:
Fibrosis is an established morphological feature of the structural myocardial remodeling that occurs in several cardiac diseases. This feature confers an increased risk for adverse cardiovascular events such as ventricular dysfunction and arrhythmias. The molecular mechanisms that lead to a fibrogenic cardiac phenotype are still being elucidated. A small number of studies have demonstrated that altered expression of several microRNAs (miRNAs) in myocardial fibrosis is associated with ischemia or mechanical overload; however, much work is still required to identify which miRNAs have a direct role in the development of fibrosis, and which develop alterations in expression that are secondary to the cardiac insult. Characterization of individual miRNAs or miRNA expression profiles that are specifically associated with myocardial fibrosis might allow us to develop diagnostic tools and innovative therapies for fibrogenic cardiac diseases.
Insights
MicroRNAs (miRNAs) play a role in cardiac fibrosis, a key factor in heart disease. Identifying specific miRNAs involved could lead to new diagnostic tools and treatments for fibrotic heart conditions.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Genetics
Background:
- Myocardial fibrosis is a hallmark of cardiac remodeling in various heart diseases.
- Fibrosis increases the risk of adverse cardiovascular events like ventricular dysfunction and arrhythmias.
- The precise molecular drivers of cardiac fibrosis are not fully understood.
Purpose of the Study:
- To investigate the role of microRNAs (miRNAs) in the development of myocardial fibrosis.
- To differentiate between miRNAs directly causing fibrosis and those with secondary expression changes.
- To identify specific miRNA profiles associated with cardiac fibrosis for potential therapeutic and diagnostic applications.
Main Methods:
- Analysis of microRNA expression in fibrotic myocardial tissue.
- Correlation of specific miRNA alterations with etiological factors like ischemia and mechanical overload.
- Investigating the direct impact of identified miRNAs on fibrotic processes.
Main Results:
- Preliminary studies suggest altered miRNA expression in myocardial fibrosis linked to ischemia or mechanical stress.
- Further research is needed to pinpoint causative miRNAs versus those with secondary expression changes.
- Characterizing specific miRNAs associated with fibrosis is crucial.
Conclusions:
- MicroRNAs represent a potential target for understanding and treating cardiac fibrosis.
- Identifying fibrosis-specific miRNAs could pave the way for novel diagnostic biomarkers.
- Targeting miRNAs may offer innovative therapeutic strategies for fibrotic heart diseases.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
01:21Myocarditis I: Introduction